References
- Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005; 308: 1592–4
- Papageorghiou AT, Campbell S. First trimester screening for preeclampsia. Curr Opin Obstet Gynecol. 2006; 18: 594–600
- Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005; 23: 337–66
- Tranguch S, Chakrabarty A, Guo Y, Wang H, Dey SK. Maternal pentraxin 3 deficiency compromises implantation in mice. Biol Reprod. 2007; 77: 425–32
- Cetin I, Cozzi V, Pasquini F, Nebuloni M, Garlanda C, Vago L, et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2006; 194: 1347–53
- Rovere-Querini P, Antonacci S, Dell'Antonio G, Angeli A, Almirante G, Dal Cin E, et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynecol. 2006; 108: 148–55
- Peri G, Introna M, Corradi D, Iacuitti G, Signorini S, Avanzini F, et al. PTX3, a prototypic long pentraxin, is an early indicator of acute myocardial infarction in man. Circulation. 2000; 102: 636–41
- Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, et al. Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol Reprod. 2007; 76: 102–17
- Popovici RM, Betzler NK, Krause MS, Luo M, Jauckus J, Germeyer A, et al. Gene expression profiling of human endometrial–trophoblast interaction in a co-culture model. Endocrinology. 2006; 147: 5662–75
- Williams MA, Farrand A, Mittendorf R, Sorensen TK, Zingheim RW, O'Reilly GC, et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55(sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol. 1999; 149: 323–9
- Newhouse SM, Davidge ST, Winkler-Lowen B, Demianczuk N, Guilbert LJ. In vitro differentiation of villous trophoblasts from pregnancies complicated by intrauterine growth restriction with and without pre-eclampsia. Placenta. 2007; 28: 999–1003
- Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic maternal inflammatory response at 18 weeks of gestation in women with subsequent preeclamsia. Br J Obstet Gynaecol. 2002; 109: 759–64